{"data":{"id":"us-mt/50-43-102","jurisdiction":"us-mt","citation":"50-43-102","heading":"Definitions.","body":"In this part, the following definitions apply:\n(1) \"Calcium-EAP\" means a calcium salt of the monoester (2-ethylamine) of phosphoric acid.\n(2) \"Harnosal\" means a compound of sulfamethizole and sulfaethidole. A 500-milligram tablet contains 350 milligrams of sulfamethizole and 150 milligrams of sulfaethidole.\n(3) \"Phosetamin\" means a compound of potassium salt of the monoester (2-ethylamine) of phosphoric acid, magnesium salt of the monoester (2-ethylamine) of phosphoric acid, and calcium salt of the monoester (2-ethylamine) of phosphoric acid. A 350-milligram tablet contains 145.8 milligrams of the potassium salt, 145.8 milligrams of the magnesium salt, and 58.4 milligrams of the calcium salt.","path":["TITLE 50. HEALTH AND SAFETY","CHAPTER 43. CALCIUM-EAP, HARNOSAL, AND PHOSETAMIN","Part 1. General Provisions"],"source_url":"https://mca.legmt.gov/bills/mca/title_0500/chapter_0430/part_0010/section_0020/0500-0430-0010-0020.html","current_through":"Montana Code Annotated 2025","vintage":"","retrieved_at":"2026-09-14T04:56:28Z","sha256":"8316b1854f5c8cf61038704d7fa11a33b28760ad5c2b4178bffa17ce8cbbabd8","source_id":"us-mt","stale":false,"prev":"us-mt/50-43-101","next":"us-mt/50-43-103"},"notice":"GroundRules: Original legal text. Not legal advice."}